This study is being done to see if Nexium I.V. can reduce and control stomach acid in mechanically ventilated, critically ill patients in an Intensive Care Unit setting.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Research SIte
Newark, Delaware, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Hershey, Pennsylvania, United States
Research Site
Memphis, Tennessee, United States
Research Site
The primary objective of the study is to assess gastric acid suppression by esomeprazole iv in critically ill subjects
The secondary objective is to assess time to stable pH greater then or equal to 4 from start of drug
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Nashville, Tennessee, United States